Ocular Therapeutix, Inc. (OCUL)
10.49
-0.13
(-1.22%)
USD |
NASDAQ |
Sep 11, 16:00
10.69
+0.20
(+1.91%)
After-Hours: 20:00
Ocular Therapeutix Market Cap : 2.303B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 2.303B |
| September 10, 2026 | 2.332B |
| September 09, 2026 | 2.519B |
| September 08, 2026 | 2.497B |
| September 04, 2026 | 2.336B |
| September 03, 2026 | 2.336B |
| September 02, 2026 | 2.394B |
| September 01, 2026 | 2.321B |
| August 31, 2026 | 2.303B |
| August 28, 2026 | 2.275B |
| August 27, 2026 | 2.376B |
| August 26, 2026 | 2.365B |
| August 25, 2026 | 2.389B |
| August 24, 2026 | 2.367B |
| August 21, 2026 | 2.433B |
| August 20, 2026 | 2.435B |
| August 19, 2026 | 2.576B |
| August 18, 2026 | 2.418B |
| August 17, 2026 | 2.339B |
| August 14, 2026 | 2.205B |
| August 13, 2026 | 2.218B |
| August 12, 2026 | 2.246B |
| August 11, 2026 | 2.143B |
| August 10, 2026 | 2.029B |
| August 07, 2026 | 2.018B |
| Date | Value |
|---|---|
| August 06, 2026 | 1.919B |
| August 05, 2026 | 1.867B |
| August 04, 2026 | 1.886B |
| August 03, 2026 | 1.845B |
| July 31, 2026 | 1.794B |
| July 30, 2026 | 1.860B |
| July 29, 2026 | 1.836B |
| July 28, 2026 | 1.850B |
| July 27, 2026 | 1.891B |
| July 24, 2026 | 1.862B |
| July 23, 2026 | 1.887B |
| July 22, 2026 | 1.879B |
| July 21, 2026 | 1.955B |
| July 20, 2026 | 1.907B |
| July 17, 2026 | 1.964B |
| July 16, 2026 | 2.006B |
| July 15, 2026 | 2.180B |
| July 14, 2026 | 2.123B |
| July 13, 2026 | 2.163B |
| July 10, 2026 | 2.233B |
| July 09, 2026 | 2.307B |
| July 08, 2026 | 2.248B |
| July 07, 2026 | 2.261B |
| July 06, 2026 | 2.115B |
| July 02, 2026 | 2.110B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| EyePoint, Inc. | 359.47M |
| Merck & Co., Inc. | 355.31B |
| Theravance Biopharma, Inc. | 882.67M |
| LENZ Therapeutics, Inc. | 142.00M |
| ANI Pharmaceuticals, Inc. | 1.612B |
Market Cap Related Metrics
| PS Ratio | 43.12 |
| PEG Ratio | -0.7005 |
| Price to Book Value | 4.429 |
| Price | 10.49 |
| Earnings Yield | -13.47% |
| PEGY Ratio | -0.7005 |